Get started
Enliven Therapeutics, Inc.Enliven Therapeutics, Inc.Enliven Therapeutics, Inc.

Enliven Therapeutics, Inc.

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasDiscussionsTechnicalsForecastSeasonalsOptionsETFs

Enliven Therapeutics, Inc. SEC filings and other documents


Explore the latest company documents and SEC filings from Enliven Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.
Description
Event date
Documents and forms
2025
Q2 2025
Aug 13, 2025
Quarterly report10-Q
Earnings release8-K
Study Update
Jun 13, 2025
Press release
Slides
Q1 2025
May 14, 2025
Quarterly report10-Q
Earnings release8-K
2024
Q4 2024
Mar 13, 2025
Annual report10-K
Earnings release8-K
Q3 2024
Nov 13, 2024
Earnings release8-K
Q2 2024
Aug 13, 2024
Earnings release8-K
Q1 2024
May 14, 2024
Earnings release8-K
Study Update
Apr 11, 2024
Slides
Investor Presentation
Feb 29, 2024
Slides
2023
Q4 2023
Mar 13, 2024
Annual report10-K
Earnings release8-K
Q3 2023
Nov 8, 2023
Earnings release8-K
Q2 2023
Aug 9, 2023
Earnings release8-K
Q1 2023
May 10, 2023
Earnings release8-K
2022
Q4 2022
Feb 10, 2023
Annual report10-K
M&A Announcement
Oct 13, 2022
Press release
Slides
2021
Q4 2021
Mar 15, 2022
Annual report10-K
2020
Q4 2020
Mar 5, 2021
Annual report10-K